Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
45.56
Dollar change
-1.08
Percentage change
-2.32
%
Index- P/E- EPS (ttm)-2.18 Insider Own17.63% Shs Outstand105.04M Perf Week1.29%
Market Cap5.43B Forward P/E- EPS next Y-0.92 Insider Trans-0.27% Shs Float98.16M Perf Month9.34%
Income-255.10M PEG- EPS next Q-0.50 Inst Own76.06% Short Float6.54% Perf Quarter5.17%
Sales618.73M P/S8.78 EPS this Y26.54% Inst Trans-1.00% Short Ratio5.04 Perf Half Y-11.62%
Book/sh6.22 P/B7.32 EPS next Y42.61% ROA-25.59% Short Interest6.42M Perf Year-2.29%
Cash/sh3.26 P/C13.97 EPS next 5Y- ROE-32.98% 52W Range33.79 - 63.57 Perf YTD-18.58%
Dividend Est.- P/FCF- EPS past 5Y-13.04% ROI-30.93% 52W High-28.33% Beta1.92
Dividend TTM- Quick Ratio4.11 Sales past 5Y35.76% Gross Margin60.41% 52W Low34.83% ATR (14)2.10
Dividend Ex-Date- Current Ratio4.69 EPS Y/Y TTM-49.04% Oper. Margin-33.03% RSI (14)46.57 Volatility4.08% 4.40%
Employees1259 Debt/Eq0.13 Sales Y/Y TTM19.81% Profit Margin-41.23% Recom1.81 Target Price57.79
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q-175.27% Payout- Rel Volume0.78 Prev Close46.64
Sales Surprise0.68% EPS Surprise-17.38% Sales Q/Q17.76% EarningsFeb 15 AMC Avg Volume1.27M Price45.56
SMA20-2.14% SMA50-5.31% SMA200-6.37% Trades Volume994,948 Change-2.32%
Date Action Analyst Rating Change Price Target Change
Dec-14-23Initiated Guggenheim Buy $60
Dec-13-23Initiated Wolfe Research Outperform $55
Dec-12-23Upgrade BofA Securities Underperform → Neutral $36 → $54
Jul-05-23Resumed JP Morgan Overweight $65
May-10-23Initiated Barclays Overweight $65
Mar-31-23Initiated Stephens Overweight $65
Feb-02-23Initiated UBS Neutral $50
Dec-14-22Initiated Deutsche Bank Buy $50
Aug-18-22Downgrade Goldman Neutral → Sell $55 → $35
Jul-25-22Initiated Canaccord Genuity Buy $55
Feb-27-24 11:55AM
Feb-20-24 04:05PM
Feb-16-24 10:21AM
08:14AM
Feb-15-24 06:00PM
05:20PM Loading…
05:20PM
04:40PM
04:17PM
04:05PM
Feb-08-24 10:00AM
Feb-07-24 04:05PM
Feb-05-24 04:05PM
11:18AM
Jan-30-24 01:03PM
Jan-24-24 04:05PM
09:00AM Loading…
Jan-08-24 09:00AM
Dec-21-23 04:05PM
Dec-20-23 04:05PM
Dec-19-23 09:00AM
Dec-13-23 04:26PM
Dec-10-23 11:59AM
Dec-07-23 09:00AM
Nov-23-23 11:05AM
Nov-19-23 09:08AM
Nov-17-23 05:22PM
Nov-09-23 01:12AM
Nov-06-23 04:05PM
Nov-03-23 11:09AM
09:14AM
Nov-02-23 07:43PM
07:30PM Loading…
07:30PM
04:52PM
04:05PM
Nov-01-23 04:05PM
Oct-31-23 10:01AM
Oct-30-23 03:45PM
Oct-26-23 04:05PM
Oct-11-23 04:05PM
Oct-10-23 12:06PM
Sep-28-23 08:23AM
Sep-19-23 01:08PM
Sep-18-23 11:52AM
Sep-14-23 04:36PM
Sep-08-23 07:37PM
Sep-05-23 09:00AM
Aug-30-23 04:05PM
Aug-29-23 04:30PM
Aug-09-23 07:14AM
Aug-04-23 04:10PM
Aug-03-23 10:00PM
06:45PM
05:40PM
04:46PM
04:05PM
Jul-13-23 04:05PM
Jul-05-23 07:30PM
Jun-01-23 09:00AM
May-25-23 11:43AM
May-24-23 04:05PM
12:30PM
May-18-23 02:57PM
11:37AM
May-17-23 04:05PM
May-14-23 04:05PM
May-04-23 06:44AM
May-03-23 05:45PM
04:05PM
Apr-27-23 12:25PM
Apr-25-23 04:06PM
Apr-12-23 04:05PM
Apr-11-23 07:13AM
Mar-07-23 09:15AM
Mar-02-23 05:47AM
Feb-22-23 04:30PM
Feb-16-23 07:13PM
Feb-15-23 05:25PM
04:05PM
Feb-09-23 10:01AM
Feb-08-23 10:00AM
Feb-06-23 09:00AM
Feb-02-23 12:58PM
Jan-19-23 04:05PM
Jan-17-23 04:10AM
Jan-10-23 12:02PM
Dec-28-22 04:05PM
Dec-22-22 07:03AM
Dec-08-22 04:05PM
Dec-06-22 05:42PM
Dec-01-22 05:28AM
Nov-09-22 04:05PM
06:14AM
Nov-04-22 07:24PM
11:37AM
Nov-02-22 05:45PM
04:05PM
Nov-01-22 02:37PM
Oct-31-22 04:05PM
Oct-24-22 11:04AM
Oct-12-22 04:05PM
Oct-07-22 10:00AM
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saxonov SergeChief Executive OfficerFeb 22Sale46.342,821130,737847,560Feb 26 04:13 PM
Hindson Benjamin J.See RemarksFeb 22Sale46.342,613121,098283,059Feb 26 04:12 PM
McAnear Justin J.Chief Financial OfficerFeb 22Sale46.341,86586,43295,240Feb 26 04:12 PM
Saxonov SergeChief Executive OfficerFeb 15Sale48.875,000244,332850,381Feb 20 04:20 PM
Saxonov SergeChief Executive OfficerFeb 09Sale49.531,00049,530855,381Feb 13 04:56 PM
Saxonov SergeChief Executive OfficerJan 16Sale45.244,000180,956856,381Jan 18 04:49 PM
Hindson Benjamin J.See RemarksDec 28Option Exercise11.488,33495,674285,672Dec 29 04:19 PM
Saxonov SergeChief Executive OfficerDec 27Option Exercise1.2014,93517,922860,381Dec 29 04:17 PM
Saxonov SergeChief Executive OfficerDec 14Sale55.032,000110,065845,446Dec 18 05:43 PM
Saxonov SergeChief Executive OfficerNov 24Sale43.723,723162,751847,446Nov 27 06:15 PM
Saxonov SergeChief Executive OfficerNov 22Sale43.343,757162,816851,169Nov 27 06:15 PM
Wilbur JamesChief Commercial OfficerNov 22Sale43.343,464150,11883,342Nov 27 06:18 PM
Hindson Benjamin J.See RemarksNov 22Sale43.343,449149,468277,338Nov 27 06:16 PM
McAnear Justin J.Chief Financial OfficerNov 22Sale43.341,67972,76297,105Nov 27 06:15 PM
Wilbur JamesChief Commercial OfficerNov 20Sale42.0914,718619,49486,806Nov 22 04:30 PM
Saxonov SergeChief Executive OfficerNov 14Sale39.522,00079,041854,926Nov 16 04:22 PM
Saxonov SergeChief Executive OfficerOct 17Sale39.511,97978,187856,926Oct 18 04:33 PM
Saxonov SergeChief Executive OfficerOct 16Sale39.5021830858,905Oct 18 04:33 PM
Saxonov SergeChief Executive OfficerSep 14Sale49.372,00098,739862,093Sep 18 04:43 PM
Wilbur JamesChief Commercial OfficerAug 22Sale45.789,699444,031101,253Aug 24 05:08 PM
Saxonov SergeChief Executive OfficerAug 22Sale45.783,757172,000864,093Aug 24 05:11 PM
Hindson Benjamin J.See RemarksAug 22Sale45.783,449157,899280,787Aug 24 05:08 PM
McAnear Justin J.Chief Financial OfficerAug 22Sale45.781,67876,82198,784Aug 24 05:09 PM
Saxonov SergeChief Executive OfficerAug 14Sale50.112,000100,212867,850Aug 16 05:11 PM
Hindson Benjamin J.See RemarksAug 01Option Exercise11.486,97080,016291,206Aug 03 04:23 PM
Hindson Benjamin J.See RemarksAug 01Sale62.216,970433,612284,236Aug 03 04:23 PM
Saxonov SergeChief Executive OfficerJul 19Option Exercise5.0420,845105,059909,850Jul 21 05:32 PM
Hindson Benjamin J.See RemarksJul 19Option Exercise5.4913,94076,492298,176Jul 21 05:31 PM
Saxonov SergeChief Executive OfficerJul 19Sale60.0340,0002,401,088869,850Jul 21 05:32 PM
Hindson Benjamin J.See RemarksJul 19Sale60.0313,940836,834284,236Jul 21 05:31 PM
Saxonov SergeChief Executive OfficerJul 14Sale58.052,000116,090889,005Jul 18 06:26 PM
Saxonov SergeChief Executive OfficerJun 14Sale58.162,000116,328891,005Jun 16 05:37 PM
STUELPNAGEL JOHN RDirectorJun 05Sale54.8910,000548,894333,736Jun 07 06:32 PM
Saxonov SergeChief Executive OfficerMay 23Sale55.062,602143,271893,190May 23 07:51 PM
Hindson Benjamin J.See RemarksMay 23Sale55.062,388131,487284,236May 25 05:49 PM
McAnear Justin J.Chief Financial OfficerMay 23Sale55.061,66591,682100,462May 25 05:48 PM
Wilbur JamesChief Commercial OfficerMay 23Sale55.0731617,401110,952May 25 05:49 PM
Saxonov SergeChief Executive OfficerMay 15Sale53.352,000106,702895,792May 17 04:35 PM
Mammen MathaiDirectorMay 11Option Exercise1.16200,000232,000202,745May 15 04:37 PM
Mammen MathaiDirectorMay 11Sale52.8233,0001,743,086169,745May 15 04:37 PM
Saxonov SergeChief Executive OfficerApr 14Sale53.822,000107,640897,792Apr 18 04:39 PM
Saxonov SergeChief Executive OfficerMar 14Sale48.882,00097,756863,405Mar 16 04:27 PM